# Protagenic Therapeutics Inc. — Form D

Protagenic Therapeutics Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-27. The offering totals $643K, of which $643K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-09-27
- Form: D
- Accession: 0001383099-13-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $643K
- Amount sold: $643K
- Investors: 5
- Date of first sale: 2013-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-203658

## Issuer

- Name: Protagenic Therapeutics Inc.
- CIK: 0001383099
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 149 5TH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Phone: 1-416-500-3305

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Garo Armen | Director | Lexington, MA |
| Khalil Barrage | Director | Boston, MA |
| Hartoun Hartounian | Director | New York, NY |
| Robert Ziroyan | Executive Officer | New York, NY |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2012-02-02](https://search.stillhousedata.com/formd/0001383099-12-000005) | D | $375K | $375K |

## More

- [CIK 1383099 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1383099&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001383099-13-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.